- Eli Lilly and Company (NYSE: LLY) is considered one of the 10 best rising dividend stocks to buy now.
- Eli Lilly’s focus on innovation and financial strength makes it a long-term winner in the healthcare sector.
- Eli Lilly’s operations currently revolve around two popular injectable GLP-1 products with promising potential for treating various conditions.
- The company projects revenue between $60 billion to $62 billion for the current year and has increased its dividend for 11 consecutive years.
- While Eli Lilly is a strong investment, some believe AI stocks offer greater upside potential with less downside risk.
Read more at Yahoo Finance: Eli Lilly’s (LLY) Focus on Innovation and Financial Strength Makes it a Long-Term Winner